LLMpediaThe first transparent, open encyclopedia generated by LLMs

Monsanto Company

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Gordon A. Cain Hop 3
Expansion Funnel Raw 62 → Dedup 35 → NER 20 → Enqueued 20
1. Extracted62
2. After dedup35 (None)
3. After NER20 (None)
Rejected: 15 (not NE: 15)
4. Enqueued20 (None)
Monsanto Company
NameMonsanto Company
TypePublic
FateAcquired by Bayer
Foundation1901 in St. Louis, Missouri
FounderJohn Francis Queeny
Defunct2018
LocationCreve Coeur, Missouri
IndustryAgrochemicals, Agricultural biotechnology
Key peopleHugh Grant (last CEO)
ProductsHerbicides, Genetically modified seeds

Monsanto Company was a major American multinational corporation specializing in agrochemicals and agricultural biotechnology. Founded in the early 20th century, it evolved from a chemical manufacturer into a global leader in genetically modified seeds and associated herbicides. Its history is marked by significant technological innovations and profound controversies, culminating in its acquisition by the German pharmaceutical and life sciences giant Bayer in 2018.

History

The company was established in 1901 in St. Louis, Missouri by John Francis Queeny, initially producing the artificial sweetener saccharin for The Coca-Cola Company. It expanded into industrial chemicals, becoming a major supplier of PCBs and Agent Orange, a herbicide used during the Vietnam War. A pivotal shift occurred in the 1980s when, under the leadership of executives like Richard J. Mahoney, it began investing heavily in molecular biology and genetic engineering. This strategic redirection led to the 1997 spin-off of its traditional chemical operations as a separate entity, Solutia, allowing the company to focus entirely on agriculture. Its final decades were defined by the commercialization of Roundup-tolerant crops and a series of major acquisitions, including the seed companies DeKalb and Seminis, before its eventual purchase by Bayer.

Products and technologies

Monsanto's most famous product line was its Roundup brand of glyphosate-based herbicides, first introduced in the 1970s. Its core agricultural technology was the development of genetically modified crops engineered for traits such as herbicide tolerance and insect resistance. Key products included "Roundup Ready" soybeans, corn, and cotton, which could withstand applications of its herbicide, and "Bt" crops incorporating genes from the bacterium Bacillus thuringiensis. The company also developed and marketed a wide array of conventionally bred vegetable seeds through its Seminis subsidiary. Other significant technologies included the bovine growth hormone rBST, marketed as Posilac, and earlier chemical products like the herbicide Lasso and the insulating fluid PCBs.

Monsanto faced extensive litigation and public criticism over its products and business practices. Major legal battles involved liability for environmental contamination from PCBs, leading to settlements with entities like the city of Anniston, Alabama. Its aggressive enforcement of patent rights and technology use agreements with farmers was challenged in cases such as Monsanto Canada Inc. v. Schmeiser. The company was a primary target of the global anti-GMO movement, facing protests from groups like Greenpeace and Via Campesina. Following its acquisition, Bayer inherited thousands of lawsuits alleging that exposure to Roundup caused non-Hodgkin lymphoma, resulting in multi-billion dollar settlements. Its lobbying efforts and influence over regulatory bodies like the U.S. Environmental Protection Agency and the Food and Drug Administration were also frequent subjects of scrutiny.

Corporate affairs

Prior to its acquisition, Monsanto was a publicly traded company on the New York Stock Exchange under the ticker symbol MON. Its last headquarters were in Creve Coeur, Missouri. Key leadership included long-serving CEO Hugh Grant. The company maintained a large intellectual property portfolio and a substantial lobbying presence in political centers like Washington, D.C. and Brussels. It engaged in numerous philanthropic and educational initiatives, often through the Monsanto Fund, though these were frequently criticized as public relations efforts. Its business model relied heavily on vertical integration in the agricultural supply chain and strategic partnerships with other biotechnology firms.

Environmental and health impacts

The environmental impact of Monsanto's products has been widely debated. The pervasive use of Roundup and Roundup Ready crops is linked to the rise of glyphosate-resistant weeds, prompting increased use of other herbicides like dicamba. Studies, including those by the International Agency for Research on Cancer, have classified glyphosate as a probable human carcinogen, a finding contested by other regulatory agencies such as the European Food Safety Authority. Historical pollution from PCBs manufactured by the company has left lasting contamination in sites like Anniston, Alabama. The introduction of Bt crops has been associated with reductions in broad-spectrum insecticide use but also raises concerns about effects on non-target organisms and insect resistance.

Category:Agricultural companies of the United States Category:Companies based in St. Louis Category:Defunct chemical companies of the United States Category:Defunct biotechnology companies